Updated Mar 26, 2019

Ankur Garg

Send Message

Ground-breaking neonatal CPAP device that leverages advances in medical research and sensor technology to provide superior respiratory support while lessening the burden on already thinly-stretched NICU nursing staff.

Initial design based off adult and existing neonatal CPAP devices, but enhanced to include key user-identified, context-specific feature sets.
Initial design based off adult and existing neonatal CPAP devices, but enhanced to include key user-identified, context-specific feature sets.
SEE LESS

Stage 3: Proof of Concept

We have done 2 years of R&D, and have presented prototype for field testing/feedback to key opinion leaders in the implementation countries. We are proceeding with human factors/usability studies, along with planning for a clinical pilot.
Registered in United Statesin United States

Focus Areas:

Maternal Newborn and Child Health, Medical Devices and Social Development

Maternal Newborn and Child Health, Medical Devices and Social DevelopmentSEE LESS

Implemented In:

Kenya, India, Rwanda and 1 MoreSEE ALL

Kenya, India, Rwanda and UgandaSEE LESS

4
Countries Implemented In
19
Employees
$1,120,000
Funds Raised to Date

Problem

Respiratory distress (RD)/Respiratory Distress Syndrome (RDS) in newborns is characterized as difficulty in breathing and poor oxygen saturation, and has a mortality rate of nearly 100% without treatment. RDS is most common in premature infants; roughly 3.2 million globally are thought to suffer from RD that CPAP (Continuous Positive Airway Pressure) could treat. The mortality rate is only 2% with appropriate treatment, but is up to 75% in low-income countries with poor health outcomes.

}

Solution

We aim to provide a viable solution for reducing respiratory distress (RD)/respiratory distress syndrome (RDS) infant mortality in the form of an improved, user-centric neonatal CPAP device. Our CPAP will provide therapy that meets or exceeds global standards and will aid overburdened nurses in their mission to minimize interruptions to the critical life-saving therapy.

Target Beneficiaries

Newborns especially in low-resource settings.

Mission and Vision

Bridge the quality healthcare gap that exists globally by preventing newborn deaths and averting Disability Adjusted Life Years (DALYs).

Competitive Advantage

• A built-in humidifier with the ability to swap out for an external humidifier • Ability to use most consumables available on the market • Internal air/O2 blending capability, with direct FiO2 adjustment and display • A smart user-centric alarm system • A portable size

Planned Goals and Milestones

• Human factors/usability studies in India and East Africa • Manufacturing Qualification • Clinical Pilot in India and East Africa

The Team Behind the Innovation

Our CEO, Krista Donaldson, has driven innovation in product design, engineering, and international development for more than 15 years, and she won acclaim as one of Fast Company’s 50 Designers Shaping the Future and a World Economic Forum Technology Pioneer. Our VP of Product Development, Ankur Garg, brings over 20 years of medical device, pharmaceutical and global health experience and she has successfully led a wide array of life-saving medical technologies from concept to commercialization.

EXECUTIVE TEAM INCLUDES WOMEN

Milestone

Mar 2019
Recognition ReceivedPENDING
Date Unknown
New Country Implemented In
Uganda
Date Unknown
New Country Implemented In
Rwanda
Date Unknown
New Country Implemented In
India
Date Unknown
New Country Implemented In
Kenya